-
Somatic_mutation_profiling_of_intestinal_crypts_from_IBD_Full_STDY
Study
EGAS00001003249
-
Custom long non-coding RNA capture enhances detection sensitivity in different human sample types.
Study
EGAS00001005418
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
Exome sequencing of synchronous colorectal cancers
Study
EGAS00001003474
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
Loss of Epigenetic Barrier is Required for Enhancer Hijacking-Mediated Oncogenic Transcription
Study
EGAS00001006140
-
WGS of MAPKi acquired resistant samples from patients and PDX models
Study
EGAS00001006874
-
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
Study
EGAS00001006631
-
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with Constitutional Mismatch Repair Deficiency
Study
EGAS00001007660
-
TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Study
EGAS00001002556
-
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS00001004407
-
Molecular Evolution of Cancer
Study
phs001255
-
Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma
Study
EGAS50000000060
-
Whole-genome and transcriptome versus panel sequencing in precision oncology: A translational-clinical comparison
Study
EGAS50000000431
-
Comprehensive genomic analysis of colorectal cancer with microsatellite instability
Study
JGAS000113
-
Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling
Study
JGAS000243
-
Analysis of mutational and proteomic heterogeneity of gastric cancer to monitor post-treatment tumor burden using circulating tumor DNA
Study
JGAS000231
-
Treatment stratification and biomarker validation using patient-derived head and neck cancer organoids
Study
EGAS00001007076
-
RB Loss in Resistant EGFR Mutant Lung Adenocarcinomas that Transform to Small Cell Lung Cancer
Study
EGAS00001001102
-
MYO5B mutations in Pheochromocytoma/Paraganglioma promote cancer progression
Study
EGAS00001003991
-
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Study
EGAS00001007029
-
CALGB/SWOG 80405: Genome-Wide Association Study of Patients with Advanced or Metastatic Colorectal Cancer Treated with First-Line Chemotherapy Combined with Cetuximab and/or Bevacizumab
Study
phs003428
-
Human Cancer-Targeted Immunity via Transgenic Hematopoietic Stem Cell Progeny
Study
phs003898
-
Single cell atlas of relapsed/refractory large B-cell lymphoma
Study
EGAS50000001293
-
Excised DNA Circles from V(D)J Recombination Promote Relapsed Leukaemia
Study
EGAS50000000407
-
Bevacizumab plus erlotinib in advanced solid cancers with Krebs cycle gene mutations: A multicenter phase II study
Study
EGAS50000001243
-
EXPRESSION OF ANTIBODY-DRUG CONJUGATE TARGETS IN BREAST CANCER METASTASES AND NORMAL TISSUE
Study
EGAS50000001334
-
Whole-genome sequencing on hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution
Study
JGAS000190
-
Molecular investigation of BCC HHI-ICI combination therapy
Study
EGAS50000001481
-
Imaging metabolic heterogeneity in breast cancer using hyperpolarized 13C-MRI
Study
EGAS00001004118
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Study
EGAS00001003306
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer RNA-Seq
Study
EGAS00001003307
-
Amplicon_based_sequencing_of_drug_resistant_lung_cancer_cell_lines
Study
EGAS00001001675
-
Cylindromas_sun_protected_and_exposed
Study
EGAS00001002521
-
Clonal architecture and genomic features of smoking versus non-smoking oncogene-driven East-Asian non-small cell lung cancer
Study
EGAS00001006942
-
Molecular Subtyping Reveals Immune Alterations Associated with Progression of Bronchial Premalignant Lesions
Study
phs003185
-
Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma
Study
phs003435
-
National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS)
Study
phs000801
-
Identifying Novel Small RNA Biomarkers Unique to Patients with Gastric Cancer
Study
phs001767
-
A Phase I Study With a Personalized Neoantigen Cancer Vaccine in Glioblastoma Multiforme
Study
phs001519
-
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients (LuCaP cell line data)
Study
EGAS50000000917
-
Development and validation of multivariate predictors of primary endocrine resistance to tamoxifen and aromatase inhibitors in luminal breast cancer reveal drug-specific differences
Study
EGAS50000001102
-
Genome and gene analysis of gastrointestinal cancer and elucidation of its clinicopathological significance
Study
JGAS000233
-
Circulating Tumor DNA in Checkpoint Inhibitor treated Lung Cancer
Study
EGAS00001004847
-
Spiradenocarcinoma
Study
EGAS00001001799
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
Histone chaperone CHAF1A promotes proliferation and tumorigenicity in gastric cancer and impacts prognosis via context-depedent regulation of gene expression
Study
EGAS00001003064